Nonclinical Development of Biologics, Vaccines and Specialty Biologics
portes grátis
Nonclinical Development of Biologics, Vaccines and Specialty Biologics
Fuller, Claudette L.; Plitnick, Lisa M.
Elsevier Science Publishing Co Inc
11/2024
450
Dura
Inglês
9780443133442
Pré-lançamento - envio 15 a 20 dias após a sua edição
Descrição não disponível.
Preface Section I:?Development of Biopharmaceuticals 1. Overview of Biopharmaceuticals and Comparison with Small-molecule Drug Development 2. Nonclinical Development of Monovalent and Polyvalent Biopharmaceuticals 3. Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological Medicines 4. Early De-risking Strategy for Novel Biotherapeutics 5. Pharmacokinetics, Pharmacodynamics, and Bioanalytics Section II:?Vaccines 6. ?Introduction to Vaccines and Adjuvants 7. Global Regulatory Guidelines for Vaccines 8. Special Considerations for the Nonclinical Safety Assessment of Vaccines Section III:?Specialty Biologics and Indications 9. Gene Therapy 10. Cell Therapy 11. Biological Therapies for Cancer 12. Considerations in the Development of Pluripotent Stem Cell-based Therapies
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
<p>Biopharmaceuticals; Biologics; Vaccines; Gene Therapy; Antibody-drug Conjugates; Cancer Therapeutics; Pharmacology; Pharmacokinetics; Nonclinical; Regulatory; Safety; Nonclinical safety assessment</p>
Preface Section I:?Development of Biopharmaceuticals 1. Overview of Biopharmaceuticals and Comparison with Small-molecule Drug Development 2. Nonclinical Development of Monovalent and Polyvalent Biopharmaceuticals 3. Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological Medicines 4. Early De-risking Strategy for Novel Biotherapeutics 5. Pharmacokinetics, Pharmacodynamics, and Bioanalytics Section II:?Vaccines 6. ?Introduction to Vaccines and Adjuvants 7. Global Regulatory Guidelines for Vaccines 8. Special Considerations for the Nonclinical Safety Assessment of Vaccines Section III:?Specialty Biologics and Indications 9. Gene Therapy 10. Cell Therapy 11. Biological Therapies for Cancer 12. Considerations in the Development of Pluripotent Stem Cell-based Therapies
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.